Programmed Cell Death Protein‐1 (PD‐1)‐Targeted Immunotherapy for Advanced Hepatocellular Carcinoma in Real World

BACKGROUND: Hepatocellular carcinoma (HCC) is one of the most common malignant solid tumors. Its incidence is increasing worldwide due to the dissemination of hepatitis B infection, HCV infection and nonalcoholic steatohepatitis-related HCC. For patients with advanced HCC, the available treatments a...

Descripción completa

Detalles Bibliográficos
Autores principales: Cui, Hanzhi, Dai, Guanghai, Guan, Jingzhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6955600/
https://www.ncbi.nlm.nih.gov/pubmed/32021262
http://dx.doi.org/10.2147/OTT.S234868

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6955600/
https://www.ncbi.nlm.nih.gov/pubmed/32021262
http://dx.doi.org/10.2147/OTT.S234868

Ejemplares similares